ERBB2 and neoplasm: In this study, we show that combined TQ and cisplatin treatment induced synergistic anti-tumor effects in cultured ID8-NGL cells, and reduced tumor burden, proliferative and apoptotic markers in ID8-NGL-derived tumors.